Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$980M |
| 2 |
Newmont
NEM
|
+$415M |
| 3 |
Moody's
MCO
|
+$313M |
| 4 |
Uber
UBER
|
+$263M |
| 5 |
AbbVie
ABBV
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$981M |
| 2 |
Microsoft
MSFT
|
+$876M |
| 3 |
HES
Hess
HES
|
+$530M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$438M |
| 5 |
Merck
MRK
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.3% |
| 2 | Healthcare | 12.26% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Adaptive Biotechnologies
ADPT
$3.94B
| $2.03M | ﹤0.01% |
414,982
+39,074
| +10% | +$178K |
|
2827
Vera Therapeutics
VERA
$2.28B
| $2.02M | ﹤0.01% |
131,318
+3,086
| +2% | +$39.2K |
|
2828
State Street Industrial Select Sector SPDR ETF
XLI
$34.8B
| $2.02M | ﹤0.01% |
17,700
-8,325
| -32% | -$874K |
|
|
ITIC
2829
Investors Title Co
ITIC
$543M
| $2.01M | ﹤0.01% |
12,422
+5,411
| +77% | +$804K |
|
2830
Castle Biosciences
CSTL
$905M
| $2.01M | ﹤0.01% |
93,308
+12,167
| +15% | +$214K |
|
|
ZIMV
2831
DELISTED
ZimVie
ZIMV
| $2.01M | ﹤0.01% |
113,280
+22,185
| +24% | +$224K |
|
2832
Treace Medical Concepts
TMCI
$312M
| $2.01M | ﹤0.01% |
157,637
-8,713
| -5% | -$88K |
|
2833
Mercer International
MERC
$31.6M
| $2.01M | ﹤0.01% |
211,811
-13,345
| -6% | -$120K |
|
2834
FS KKR Capital
FSK
$3.42B
| $2M | ﹤0.01% |
100,008
+3,484
| +4% | +$68.4K |
|
2835
Primis Financial Corp
FRST
$413M
| $2M | ﹤0.01% |
157,741
-3,323
| -2% | -$32.4K |
|
2836
Clearfield
CLFD
$391M
| $1.99M | ﹤0.01% |
68,542
-33,839
| -33% | -$902K |
|
2837
argenx
ARGX
$53.3B
| $1.99M | ﹤0.01% |
5,227
-146
| -3% | -$68K |
|
|
RPC
2838
Ridgepost Capital
RPC
$956M
| $1.99M | ﹤0.01% |
194,564
+1,615
| +0.8% | +$16K |
|
2839
Avantis Emerging Markets Equity ETF
AVEM
$26.9B
| $1.98M | ﹤0.01% |
35,091
+9,677
| +38% | +$521K |
|
2840
iShares US Real Estate ETF
IYR
$4.59B
| $1.97M | ﹤0.01% |
21,526
-2,581
| -11% | -$211K |
|
2841
Peoples Financial Services
PFIS
$714M
| $1.97M | ﹤0.01% |
40,363
-6,403
| -14% | -$274K |
|
|
SRDX
2842
DELISTED
Surmodics
SRDX
| $1.96M | ﹤0.01% |
53,946
+3,262
| +6% | +$107K |
|
2843
Pulmonx
LUNG
$104M
| $1.96M | ﹤0.01% |
153,531
-6,181
| -4% | -$64.4K |
|
|
OLPX
2844
DELISTED
Olaplex Holdings
OLPX
| $1.95M | ﹤0.01% |
769,649
+266,982
| +53% | +$527K |
|
|
ALPN
2845
DELISTED
Alpine Immune Sciences Inc
ALPN
| $1.95M | ﹤0.01% |
102,352
+9,629
| +10% | +$134K |
|
2846
Asure Software
ASUR
$245M
| $1.95M | ﹤0.01% |
204,558
+25,239
| +14% | +$211K |
|
2847
Clarus
CLAR
$140M
| $1.95M | ﹤0.01% |
282,431
+183,911
| +187% | +$1.08M |
|
2848
Evolv Technologies
EVLV
$1.05B
| $1.93M | ﹤0.01% |
409,747
+9,116
| +2% | +$39K |
|
|
CSTR
2849
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.93M | ﹤0.01% |
103,142
-282,512
| -73% | -$4.61M |
|
2850
Aviat Networks
AVNW
$287M
| $1.93M | ﹤0.01% |
59,121
+2,049
| +4% | +$61.2K |
|
Similar funds
Bank of New York Mellon's Q4 2023 Portfolio in Review
As of Q4 2023, Bank of New York Mellon held 4,468 positions worth $493B, up 8.4% from $455B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q4 2023 filing shows 126 new, 1,615 increased, 2,238 reduced and 158 closed positions. Its largest new stake was Veralto: 3,360,679 shares worth $276M. The largest sale was Apple, an estimated $981M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2023 buy was Veralto: 3,360,679 shares worth $276M.
- Bank of New York Mellon added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $980M increase.
- Bank of New York Mellon's biggest Q4 2023 reduction was Apple, cutting an estimated $981M.
- Bank of New York Mellon fully exited Activision Blizzard in Q4 2023, selling an estimated $438M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $493B portfolio in Q4 2023.
- Bank of New York Mellon opened 126 new positions and closed 158 in Q4 2023.
- Bank of New York Mellon's portfolio value rose 8.4% quarter-over-quarter to $493B.
Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.